Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Benchling Partners with Anthropic to Build a Bridge Between Science and AI

This image opens in the lightbox

News provided by

Benchling

20 Oct, 2025, 16:00 GMT

Share this article

Share toX

Share this article

Share toX

Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude

SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling's trusted data foundation and AI agents with Claude's advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. Benchling AI agents in Claude handle the heavy-lifting of searching structured data like assay results and molecules and pulling unstructured context buried in lab notebooks, so scientists can focus on analysis and decisions.

Continue Reading
This image opens in the lightbox
How scientists are using Benchling AI in Claude today.
This image opens in the lightbox
R&D use cases for Benchling AI in Claude

Building the AI ecosystem for biotech

AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could "compress decades of biological progress into just a few years," opening the door to far better prevention and treatment across diseases. Getting there requires operationalizing AI: pairing advanced models with trustworthy, secure data; purpose-built workflows; and access for every scientist.

"AI in R&D only works through an ecosystem. Anthropic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first," said Ashu Singhal, Co-founder and President of Benchling. "Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we're building AI that powers this next chapter of R&D."

"We're connecting Claude to the systems science already runs on. With Benchling's trusted data foundation and AI workflows, Claude helps teams move from research questions to results faster, at lab, program, and portfolio scale," said Eric Kauderer-Abrams, Head of Life Sciences and Biology, Anthropic.

What scientists can do today

Claude for Life Sciences leverages Benchling as the system of record while Claude synthesizes insights across the data. The integration between Claude and Benchling is possible via Model Context Protocol (MCP), and enables users to move seamlessly between the two, with one-click traceability to the underlying scientific data. Existing permissions and audit logs carry over automatically, so organizations can roll out AI across R&D while maintaining control and compliance.

Here's how researchers, program leads, bioinformaticians, and scientists are using Benchling in Claude. 

Category

Example prompt

Recommendations

"Based on our last three in vivo results in Benchling and recent FDA guidance, what should we test next?"

Portfolio insights

"Aggregate results from our top five programs and highlight which ones are showing the strongest early efficacy signals compared with industry benchmarks."

Workflow orchestration

"Pull my Benchling assay results and check for related compound data to see if we've already profiled these molecules."

Cross-source comparison

"Compare the IC50 results from my last two Benchling experiments with recent PubMed articles on AAV stability."

Multi-tool reporting

"Draft a report that combines Benchling notebook data with statistical analyses to create a single study summary."

Access and availability

Benchling's AI agents in the Claude for Life Sciences ecosystem are available to Benchling customers with Benchling AI enabled. Customers should reach out to their account teams for set-up and more information.  

About Benchling
Benchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups to global biopharmas like Merck, Moderna, and Sanofi. Benchling's products help scientists capture, connect, and analyze data across the R&D lifecycle. With Benchling AI, scientists use agents and models directly in their workflows, connected to structured data. The result: faster teams, better molecules, and breakthroughs for all.

About Anthropic

Anthropic is an AI research and development company that creates reliable, interpretable, and steerable AI systems. Anthropic's flagship product is Claude, a large language model trusted by millions of users worldwide. Anthropic's flagship product is Claude, a family of foundational AI models purpose-built for business tasks. Visit www.anthropic.com for more information.

Video - https://mma.prnewswire.com/media/2799822/Benchling_Anthropic_1080p.mp4
Photo - https://mma.prnewswire.com/media/2799821/R_and_D_use_cases_for_Benchling_AI_in_Claude.jpg
Logo - https://mma.prnewswire.com/media/2790281/Benchling_Logo.jpg

Modal title

Also from this source

Benchling Reveals the Next Chapter of R&D at Benchtalk 2025

Benchling Reveals the Next Chapter of R&D at Benchtalk 2025

Benchling today unveiled major new capabilities at Benchtalk, its annual customer conference. These new releases are designed to help biotech...

Benchling and Moderna Collaborate on AI-Driven Research

Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Artificial Intelligence

Artificial Intelligence

Computer & Electronics

Computer & Electronics

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.